Pepex Biomedical, Inc.

Pepex Biomedica is development-stage medical device contract development and manufacturing organization (CDMO) focused on electrochemical biosensors. After over 20 years of sustained R&D, the Company is now prepared to commercialize its industry-disruptive technology through a wide range of diagnostic test product use cases. At present, Pepex has created an extensive Intellectual Property (IP) portfolio of +30 global patents that protect its proprietary manufacturing processes and biosensor designs capable of identifying hundreds of unique biomarkers which indicate the presence, and in certain situations the concentration level of, cancers, lactic acid, sepsis, Alzheimer's, HIV, Ebola, hepatitis, Traumatic Brain Injury (TBI), tuberculosis, CV-19, and other life-altering conditions quickly, easily, and cost effectively in saliva, blood, and interstitial fluid. Pepex Biosensor Technology (PBT) applications involve integrating from 1 to many polyetheretherketone (PEEK) fibers, each roughly the size of a human hair, inside a physical space as small as a 32-guage cannula. Using the Company's patented three-dimensional, nanoparticle Aerosol Jet Printing (AJP) techniques, analyte-specific chemistry is applied to PEEK fibers which may be inserted into a range of various sizes and form factors for specific use cases. Recently, the Company has also developed its AnalyteAI™ artificial intelligence competency which may be applied to provide near real-time data analysis of diagnostic samples.

• Employees 5
• Founded 1996
• Annual Revenue $26900000
• Total Funding $10201670